Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cd46db19f76693118780d061d250cc83 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-732 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate |
2011-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2016-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42f22395f833061e361cdfd467ba5812 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26a07afd38f666101919baf07bdf7ac2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb696c7d2aec8d650446c5a1528645cd |
publicationDate |
2016-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
RU-2597971-C2 |
titleOfInvention |
Pharmaceutical composition for treatment and/or prevention of cancer |
abstract |
FIELD: biochemistry. n SUBSTANCE: invention is related to biochemistry, particularly to the drug for treatment or prevention of the CAPRIN-1 expressing cancer. Also disclosed are antibodies possessing immunologic activity with respect to CAPRIN-1, therapeutic agent containing the said antibodies and a monoclonal antibody which is specifically bound to the CAPRIN-1 protein. Disclosed is a method of treatment or prevention of CAPRIN-1 expressing cancer. n EFFECT: invention provides effective treatment of the mediated CAPRIN-1 cancer. n 15 cl, 2 dwg, 7 ex |
priorityDate |
2010-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |